Absorption, distribution and excretion of 14C‐chloroquine after single oral administration in albino and pigmented rats: binding characteristics of chloroquine‐related radioactivity to melanin in‐vivo
Identifieur interne : 000209 ( Istex/Curation ); précédent : 000208; suivant : 000210Absorption, distribution and excretion of 14C‐chloroquine after single oral administration in albino and pigmented rats: binding characteristics of chloroquine‐related radioactivity to melanin in‐vivo
Auteurs : Chiho Ono [Japon] ; Masayoshi Yamada [Japon] ; Makoto Tanaka [Japon]Source :
- Journal of Pharmacy and Pharmacology [ 0022-3573 ] ; 2003-12.
English descriptors
- Teeft :
- Albino, Albino rats, Binding characteristics, Binding mechanisms, Chloroquine, Chloroquine diphosphate, Corpus vitreum, Critical role, Diphosphate, Distinct affinity, Dosing, Electrostatic interaction, Equiv, Excretion, Excretion pattern, Faeces, High affinity, Important role, Larsson, Larsson tjalve, Lindquist ullberg, Lower limit, Maximum value, Melanin, Neutral phosphate buffer, Ocular, Ocular tissues, Oral dosing, Phosphate buffer, Radioactivity, Radioactivity concentrations, Rat, Serum concentrations, Stepien wilczok, Strong binding, Synthetic melanin, Tanaka, Testis, Tjalve, Total radioactivity, Urine, Uveal, Uveal tract, Uveal tract concentrations, Uveal tract radioactivity concentrations, Uveal tracts, Vitreum.
Abstract
Chloroquine is an antimalarial agent that has been reported to have distinct affinity to melanin. After single oral administration of 14C‐chloroquine at a dose of 20 mg kg−1 under non‐fasting conditions, the absorption, distribution and excretion of 14C‐chloroquine‐related radioactivity were studied in albino and pigmented rats. The objectives of the study were to investigate differences in the disposition of chloroquine between albino and pigmented rats and to define its in‐vivo binding characteristics to melanin‐containing ocular tissues. Extensive uptake of radioactivity into tissues was indicated by higher concentrations in most tissues compared with serum and there was no quantitative differences in the distribution of radioactivity found between albino and pigmented rats except for melanin‐containing tissues, such as the uveal tract of the eye and perhaps hair follicles. There was selective and strong binding of drug‐related compounds to these tissues in pigmented rats. The uveal tract concentrations reached the maximum value of 158.42 + 7.86 μg equiv g−1 (mean + s.e.) at 1 week and decreased very slowly with a terminal half life of 4476h (187 day). The uveal tract concentrations at 24 weeks were still high (67.75 + 6.19 μg equiv g−1). The AUC for uveal tract was 842.3 mg h g−1. A relatively high concentration was still determined in the uveal tract even at 48 weeks after single oral dosing by whole‐body autoradiography. The uveal tracts separated from one eye of each rat were extracted with 0.067 m phosphate buffer (pH 7.4) and 1 m HCl–EtOH (30:70) successively. In pigmented rats, almost all radioactivity was released from the tissue with 1 m HCl–EtOH (30:70), indicating that the strong binding by melanin was reversible, and that hydrophobic or electrostatic interaction would play a critical role in the binding of chloroquine and its metabolites with the melanin‐containing ocular tissues. Approximately 70% of the radioactivity given was recovered in urine and faeces up to 144h after dosing both in pigmented and albino rats. The excretion pattern in pigmented rats was similar to that seen in albino rats.
Url:
DOI: 10.1211/0022357022340
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000209
Links to Exploration step
ISTEX:074F7E16AA37A79EFD60DB54E18B9DCD5817ED2ALe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Absorption, distribution and excretion of 14C‐chloroquine after single oral administration in albino and pigmented rats: binding characteristics of chloroquine‐related radioactivity to melanin in‐vivo</title>
<author><name sortKey="Ono, Chiho" sort="Ono, Chiho" uniqKey="Ono C" first="Chiho" last="Ono">Chiho Ono</name>
<affiliation wicri:level="1"><mods:affiliation>Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd, 16–13, Kita‐Kasai 1‐Chome, Edogawa‐ku, Tokyo 134–8630, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd, 16–13, Kita‐Kasai 1‐Chome, Edogawa‐ku, Tokyo 134–8630</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Yamada, Masayoshi" sort="Yamada, Masayoshi" uniqKey="Yamada M" first="Masayoshi" last="Yamada">Masayoshi Yamada</name>
<affiliation wicri:level="1"><mods:affiliation>Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd, 16–13, Kita‐Kasai 1‐Chome, Edogawa‐ku, Tokyo 134–8630, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd, 16–13, Kita‐Kasai 1‐Chome, Edogawa‐ku, Tokyo 134–8630</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Tanaka, Makoto" sort="Tanaka, Makoto" uniqKey="Tanaka M" first="Makoto" last="Tanaka">Makoto Tanaka</name>
<affiliation wicri:level="1"><mods:affiliation>Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd, 16–13, Kita‐Kasai 1‐Chome, Edogawa‐ku, Tokyo 134–8630, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd, 16–13, Kita‐Kasai 1‐Chome, Edogawa‐ku, Tokyo 134–8630</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>E-mail: tanak6m1@daiichipharm.co.jp</mods:affiliation>
<country wicri:rule="url">Japon</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:074F7E16AA37A79EFD60DB54E18B9DCD5817ED2A</idno>
<date when="2003" year="2003">2003</date>
<idno type="doi">10.1211/0022357022340</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-4L384X5G-S/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000209</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000209</idno>
<idno type="wicri:Area/Istex/Curation">000209</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Absorption, distribution and excretion of 14C‐chloroquine after single oral administration in albino and pigmented rats: binding characteristics of chloroquine‐related radioactivity to melanin in‐vivo</title>
<author><name sortKey="Ono, Chiho" sort="Ono, Chiho" uniqKey="Ono C" first="Chiho" last="Ono">Chiho Ono</name>
<affiliation wicri:level="1"><mods:affiliation>Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd, 16–13, Kita‐Kasai 1‐Chome, Edogawa‐ku, Tokyo 134–8630, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd, 16–13, Kita‐Kasai 1‐Chome, Edogawa‐ku, Tokyo 134–8630</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Yamada, Masayoshi" sort="Yamada, Masayoshi" uniqKey="Yamada M" first="Masayoshi" last="Yamada">Masayoshi Yamada</name>
<affiliation wicri:level="1"><mods:affiliation>Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd, 16–13, Kita‐Kasai 1‐Chome, Edogawa‐ku, Tokyo 134–8630, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd, 16–13, Kita‐Kasai 1‐Chome, Edogawa‐ku, Tokyo 134–8630</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Tanaka, Makoto" sort="Tanaka, Makoto" uniqKey="Tanaka M" first="Makoto" last="Tanaka">Makoto Tanaka</name>
<affiliation wicri:level="1"><mods:affiliation>Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd, 16–13, Kita‐Kasai 1‐Chome, Edogawa‐ku, Tokyo 134–8630, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd, 16–13, Kita‐Kasai 1‐Chome, Edogawa‐ku, Tokyo 134–8630</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>E-mail: tanak6m1@daiichipharm.co.jp</mods:affiliation>
<country wicri:rule="url">Japon</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Journal of Pharmacy and Pharmacology</title>
<title level="j" type="alt">JOURNAL OF PHARMACY AND PHARMACOLOGY</title>
<idno type="ISSN">0022-3573</idno>
<idno type="eISSN">2042-7158</idno>
<imprint><biblScope unit="vol">55</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="1647">1647</biblScope>
<biblScope unit="page" to="1654">1654</biblScope>
<biblScope unit="page-count">8</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2003-12">2003-12</date>
</imprint>
<idno type="ISSN">0022-3573</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0022-3573</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Albino</term>
<term>Albino rats</term>
<term>Binding characteristics</term>
<term>Binding mechanisms</term>
<term>Chloroquine</term>
<term>Chloroquine diphosphate</term>
<term>Corpus vitreum</term>
<term>Critical role</term>
<term>Diphosphate</term>
<term>Distinct affinity</term>
<term>Dosing</term>
<term>Electrostatic interaction</term>
<term>Equiv</term>
<term>Excretion</term>
<term>Excretion pattern</term>
<term>Faeces</term>
<term>High affinity</term>
<term>Important role</term>
<term>Larsson</term>
<term>Larsson tjalve</term>
<term>Lindquist ullberg</term>
<term>Lower limit</term>
<term>Maximum value</term>
<term>Melanin</term>
<term>Neutral phosphate buffer</term>
<term>Ocular</term>
<term>Ocular tissues</term>
<term>Oral dosing</term>
<term>Phosphate buffer</term>
<term>Radioactivity</term>
<term>Radioactivity concentrations</term>
<term>Rat</term>
<term>Serum concentrations</term>
<term>Stepien wilczok</term>
<term>Strong binding</term>
<term>Synthetic melanin</term>
<term>Tanaka</term>
<term>Testis</term>
<term>Tjalve</term>
<term>Total radioactivity</term>
<term>Urine</term>
<term>Uveal</term>
<term>Uveal tract</term>
<term>Uveal tract concentrations</term>
<term>Uveal tract radioactivity concentrations</term>
<term>Uveal tracts</term>
<term>Vitreum</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Chloroquine is an antimalarial agent that has been reported to have distinct affinity to melanin. After single oral administration of 14C‐chloroquine at a dose of 20 mg kg−1 under non‐fasting conditions, the absorption, distribution and excretion of 14C‐chloroquine‐related radioactivity were studied in albino and pigmented rats. The objectives of the study were to investigate differences in the disposition of chloroquine between albino and pigmented rats and to define its in‐vivo binding characteristics to melanin‐containing ocular tissues. Extensive uptake of radioactivity into tissues was indicated by higher concentrations in most tissues compared with serum and there was no quantitative differences in the distribution of radioactivity found between albino and pigmented rats except for melanin‐containing tissues, such as the uveal tract of the eye and perhaps hair follicles. There was selective and strong binding of drug‐related compounds to these tissues in pigmented rats. The uveal tract concentrations reached the maximum value of 158.42 + 7.86 μg equiv g−1 (mean + s.e.) at 1 week and decreased very slowly with a terminal half life of 4476h (187 day). The uveal tract concentrations at 24 weeks were still high (67.75 + 6.19 μg equiv g−1). The AUC for uveal tract was 842.3 mg h g−1. A relatively high concentration was still determined in the uveal tract even at 48 weeks after single oral dosing by whole‐body autoradiography. The uveal tracts separated from one eye of each rat were extracted with 0.067 m phosphate buffer (pH 7.4) and 1 m HCl–EtOH (30:70) successively. In pigmented rats, almost all radioactivity was released from the tissue with 1 m HCl–EtOH (30:70), indicating that the strong binding by melanin was reversible, and that hydrophobic or electrostatic interaction would play a critical role in the binding of chloroquine and its metabolites with the melanin‐containing ocular tissues. Approximately 70% of the radioactivity given was recovered in urine and faeces up to 144h after dosing both in pigmented and albino rats. The excretion pattern in pigmented rats was similar to that seen in albino rats.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000209 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000209 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Istex |étape= Curation |type= RBID |clé= ISTEX:074F7E16AA37A79EFD60DB54E18B9DCD5817ED2A |texte= Absorption, distribution and excretion of 14C‐chloroquine after single oral administration in albino and pigmented rats: binding characteristics of chloroquine‐related radioactivity to melanin in‐vivo }}
This area was generated with Dilib version V0.6.33. |